Mitochondria of a human multidrug-resistant hepatocellular carcinoma cell line constitutively express inducible nitric oxide synthase in the inner membrane

Journal of Cellular and Molecular Medicine

Volumn 19, Issue 6, 2015, Pages 1410-1417

  Fantappiè, Ornella ^a   Sassoli, Chiara ^b   Tani, Alessia ^b   Nosi, Daniele ^b   Marchetti, Serena ^c   Formigli, Lucia ^b   Mazzanti, Roberto ^a  

^a CAREGGI UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

COX 2; Coxib; iNOS; MDR; Mitochondrion

Indexed keywords

CELECOXIB; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; MULTIDRUG RESISTANCE PROTEIN; NOS2 PROTEIN, HUMAN; PTGS2 PROTEIN, HUMAN;

CONFOCAL MICROSCOPY; DRUG EFFECTS; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOELECTRON MICROSCOPY; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; MULTIDRUG RESISTANCE; PATHOLOGY; TUMOR CELL LINE; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELECOXIB; CELL LINE, TUMOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MICROSCOPY, CONFOCAL; MICROSCOPY, IMMUNOELECTRON; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; NITRIC OXIDE SYNTHASE TYPE II; P-GLYCOPROTEIN;

EID: 84929948879     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12528     Document Type: Article

References (35)

1. Staud F, Ceckova M, Micuda S, et al. Expression and function of p-glycoprotein in normal tissues: effect on pharmacokinetics. Methods Mol Biol. 2010; 596: 199-222.
2. Ni ZL, Bikadi Z, Rosenberg MF, et al. Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). Curr Drug Metab. 2010; 11: 603-17.
3. Sharom FJ. ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics. 2008; 9: 105-27.
4. Solazzo M, Fantappie O, Lasagna N, et al. P-gp localization in mitochondria and its functional characterization in multiple drug-resistant cell lines. Exp Cell Res. 2006; 312: 4070-8.
5. Shen Y, Chu Y, Yang Y, et al. Mitochondrial localization of P-glycoprotein in the human breast cancer cell line MCF-7/ADM and its functional characterization. Oncol Rep. 2012; 27: 1535-40.
6. Solazzo M, Fantappie O, D'Amico M, et al. Mitochondrial expression and functional activity of breast cancer resistance protein in different multiple drug-resistant cell lines. Cancer Res. 2009; 69: 7235-42.
7. Jungsuwadee P, Nithipongvanitch R, Chen Y, et al. Mrp1 localization and function in cardiac mitochondria after doxorubicin. Mol Pharmacol. 2009; 75: 1117-26.
8. Fu D, Arias IM. Intracellular trafficking of P-glycoprotein. Int J Biochem Cell Biol. 2012; 44: 461-4.
9. Roundhill EA, Burchill SA. Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria. Br J Cancer. 2012; 106: 1224-33.
10. Bendayan R, Ronaldson PT, Gingras D, et al. In situ localization of P-glycoprotein (ABCB1) in human and rat brain. J Histochem Cytochem. 2006; 54: 1159-67.
11. Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer. 2010; 10: 181-93.
12. Patel VA, Dunn MJ, Sorokin A. Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2. J Biol Chem. 2002; 277: 38915-20.
13. Kalalinia F, Elahian F, Behravan J. Potential role of cyclooxygenase-2 on the regulation of the drug efflux transporter ABCG2 in breast cancer cell lines. J Cancer Res Clin Oncol. 2011; 137: 321-30.
14. Takaoka K, Kishimoto H, Segawa E, et al. In vitro susceptibility to anticancer agents of the human KB carcinoma cell line transfected with COX-2 cDNA. Oncol Rep. 2008; 20: 645-9.
15. Fantappie O, Masini E, Sardi I, et al. The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line. Hepatology. 2002; 35: 843-52.
16. Fantappie O, Solazzo M, Lasagna N, et al. P-glycoprotein mediates celecoxib-induced apoptosis in multiple drug-resistant cell lines. Cancer Res. 2007; 67: 4915-23.
17. Lasagna N, Fantappie O, Solazzo M, et al. Hepatocyte growth factor and inducible nitric oxide synthase are involved in multidrug resistance-induced angiogenesis in hepatocellular carcinoma cell lines. Cancer Res. 2006; 66: 2673-82.
18. Suryo Rahmanto Y, Kalinowski DS, Lane DJ, et al. Nitrogen monoxide (NO) storage and transport by dinitrosyl-dithiol-iron complexes: long-lived NO that is trafficked by interacting proteins. J Biol Chem. 2012; 287: 6960-8.
19. Gupta N, Martin PM, Miyauchi S, et al. Down-regulation of BCRP/ABCG2 in colorectal and cervical cancer. Biochem Biophys Res Commun. 2006; 343: 571-7.
20. Sonveaux P, Jordan BF, Gallez B, et al. Nitric oxide delivery to cancer: why and how? Eur J Cancer. 2009; 45: 1352-69.
21. Singh S, Gupta AK. Nitric oxide: role in tumour biology and iNOS/NO-based anticancer therapies. Cancer Chemother Pharmacol. 2011; 67: 1211-24.
22. Olson SY, Garban HJ. Regulation of apoptosis-related genes by nitric oxide in cancer. Nitric Oxide. 2008; 19: 170-6.
23. Leon L, Jeannin JF, Bettaieb A. Post-translational modifications induced by nitric oxide (NO): implication in cancer cells apoptosis. Nitric Oxide. 2008; 19: 77-83.
24. Nunnari J, Suomalainen A. Mitochondria: in sickness and in health. Cell. 2012; 148: 1145-59.
25. Wallace DC. Mitochondria and cancer. Nat Rev Cancer. 2012; 12: 685-98.
26. Da Cruz S, Xenarios I, Langridge J, et al. Proteomic analysis of the mouse liver mitochondrial inner membrane. J Biol Chem. 2003; 278: 41566-71.
27. Kojima H, Endo K, Moriyama H, et al. Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance. J Biol Chem. 1998; 273: 16647-50.
28. MacNab GM, Alexander JJ, Lecatsas G, et al. Hepatitis B surface antigen produced by a human hepatoma cell line. Br J Cancer. 1976; 34: 509-15.
29. Maier TJ, Janssen A, Schmidt R, et al. Targeting the beta-catenin/APC pathway: a novel mechanism to explain the cyclooxygenase-2-independent anticarcinogenic effects of celecoxib in human colon carcinoma cells. FASEB J. 2005; 19: 1353-5.
30. Paterson JK, Gottesman MM. P-Glycoprotein is not present in mitochondrial membranes. Exp Cell Res. 2007; 313: 3100-5.
31. Bolte S, Cordelieres FP. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc. 2006; 224: 213-32.
32. Varecha M, Amrichova J, Zimmermann M, et al. Bioinformatic and image analyses of the cellular localization of the apoptotic proteins endonuclease G, AIF, and AMID during apoptosis in human cells. Apoptosis. 2007; 12: 1155-71.
33. Liu H, Huang P, Xu X, et al. Anticancer effect of celecoxib via COX-2 dependent and independent mechanisms in human gastric cancers cells. Dig Dis Sci. 2009; 54: 1418-24.
34. Malka D, Pacault V, De Baere T, et al. Antitumoral effect of celecoxib in hepatocellular carcinoma. J Clin Oncol. 2005; 23: 4805-6.
35. Bastos-Pereira AL, Lugarini D, Oliveira-Christoff A, et al. Celecoxib prevents tumor growth in an animal model by a COX-2 independent mechanism. Cancer Chemother Pharmacol. 2010; 65: 267-76.